Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Animal Exposure to Treatment Failure: Optimized Regimens in Brucellosis
October 2025
Network meta-analysis ranks brucellosis treatment regimens, finding triple-drug combinations outperform widely used dual therapies.
Read more
25 Jun 2025
Emerging Biologics in Treating Pemphigus and Bullous Pemphigoid
Emerging immunotherapies are transforming the treatment landscape for pemphigus and bullous pemphigoid, two distinct autoimmune blistering skin diseases marked by pathogenic autoantibodies and significant patient burden.
23 Jun 2025
IL-23 Inhibitor Resolves Severe Psoriasis Triggered by Adalimumab
In a compelling case that underscores the complexity of biologic therapies, a patient with hidradenitis suppurativa (HS) developed adalimumab-induced pustular psoriasis, which was successfully treated with guselkumab.
16 Jun 2025
JAK Inhibitor Acne Common in Middle-Aged IBD
Acne has emerged as a frequent and clinically relevant side effect in patients with inflammatory bowel disease (IBD) treated with JAK inhibitors, according to the largest international retrospective cohort study to date on this adverse event.
13 Jun 2025
Why Are Cashew and Almond Allergies on the Rise?
A growing number of anaphylaxis cases linked to cashew nuts, especially in children, combined with an unexpected frequency of almond-induced reactions in adults, signals a shift in the landscape of tree nut allergies, according to new data from the European Anaphylaxis Registry.
11 Jun 2025
Autistic Individuals Face Major Barriers in Dermatologic Care
Autistic individuals face major barriers in dermatologic care, and a new review urges systemic reform to advance equity and improve outcomes.
9 Jun 2025
Fitness Tech Vibration Devices May Trigger Itch
Whole body vibration (WBV) training may trigger itch and erythema in a significant portion of users, with side-to-side vibration devices posing a higher risk, according to a new multicenter study.
6 Jun 2025
Mohs Surgery Alone Outperforms Combo With Photodynamic Therapy
New research suggests that Mohs micrographic surgery (MMS) alone may lead to lower recurrence rates than when combined with photodynamic therapy (PDT) in treating locally advanced basal cell carcinoma (laBCC), particularly in non-aggressive subtypes.
4 Jun 2025
Laser Dermatology in the US: Are Patients Sacrificing Safety for Speed?
A new study reveals major differences in cosmetic laser practices across US dermatologists, plastic surgeons, and medical spas. Key findings raise patient safety concerns and emphasize the importance of specialized training.
Loading posts...
« Previous
1
…
4
5
6
7
8
…
17
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View